Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including...
angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 24, 2022 8:58pm
Still waiting until volume and share price increasing
Before i buy back in.
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Post by
TRADERCONNECTS
on Jun 24, 2022 3:01pm
Hemostemix Inc (OTC: HMTXF) (TSXV: HEM) Announces Closure of
https://otcactions.blogspot.com/2022/06/hemostemix-inc-otc-hmtxf-tsxv-hem.html
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(2)
•••
ashokswain861
X
View Profile
View Bullboard History
Post by
ashokswain861
on Jun 24, 2022 2:48pm
Hemostemix Inc. (OTC: HMTXF) (TSXV: HEM) announces
Hemostemix Inc. (OTC: HMTXF) (TSXV: HEM) announces incorporation of PreCerv https://www.tumblr.com/blog/view/myarcadeenthusiast/687965173032566784?source=share
(6)
•••
Tradeconnects
X
View Profile
View Bullboard History
Comment by
Tradeconnects
on Jun 24, 2022 2:21pm
RE:$HEM expansion of the common share and warrant within
$HEM an outstandingly volatile stock Investment on the TSX-V,
(3)
•••
DRJENNY
X
View Profile
View Bullboard History
Post by
DRJENNY
on Jun 24, 2022 12:09pm
$HEM expansion of the common share and warrant within
The recently announced private placement of 15 million units, in which each full unit consists of one common share and one purchase warrant, each full warrant entitles the holder to acquire one common
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 24, 2022 12:01pm
$HEM reports non-brokered private placement of 15 million un
Hemostemix disclosed a non-brokered private offering of about 15 million units to shareholders, priced in the context of the market, with each unit consisting of one common share and one common share
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 24, 2022 10:45am
$HMTXF common share and warrant elaboration
The recently announced private placement of 15 million units has put the entire OTC in awe, in which each full unit consists of one common share and one purchase warrant, each full warrant entitles
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 24, 2022 10:28am
$HMTXF announced closure of the first tranche of the unit pr
$HMTXF have successfully closed the first tranche of the announced on May 29. 2 022 for gross proceeds of $690,388.80. The Offering contained the issuance of a collective of 2,301,296 Units at a
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 24, 2022 9:45am
$HMTXF get backs all its intellectual property
Hemostemix is now in possession of all of its intellectual property, including all HS 12-01 Phase II clinical trial data, all historical data from Hemostemix Israel, and the randomization tables that
...more
(13)
•••
trade007
X
View Profile
View Bullboard History
Post by
trade007
on Jun 24, 2022 8:37am
CEO Hemostemix highlighted the mounting demand of $HEM.
Thomas Smeenk on the latest update stated “for the stem cell space it is the right time to take a bite of the apple” Thomas later said the management board have invested about $4.5 Million in the
...more
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Jun 24, 2022 8:15am
RE:Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) keeping investors o
Note the final sentence, "HEM and HMTXF are surely a commendable investment as the stocks exhibit explosive nature and aggressive bull run is en-route for the stock". Interesting....
(2)
•••
zames007
X
View Profile
View Bullboard History
Post by
zames007
on Jun 23, 2022 3:35pm
CEO Hemostemix highlighted the mounting demand of $HEM.
Thomas Smeenk on the latest update stated “for the stem cell space it is the right time to take a bite of the apple” Thomas later said the management board have invested about $4.5 Million in the
...more
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Post by
TRADERCONNECTS
on Jun 23, 2022 3:17pm
Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) keeping investors o
https://investorconnect.livejournal.com/394.html
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 23, 2022 3:07pm
Hemostemix Inc. interest payment on convertible debenture
Hemostemix Inc. announced that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 23, 2022 2:35pm
Hemostemix Inc. (OTC: HMTXF) (TSXV: HEM) a worth full stock
https://medium.com/@subash.bluedigitalmedia/hemostemix-inc-otc-hmtxf-tsxv-hem-a-worth-full-stock-investment-72b39525ae3b
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project